UTH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - United Therapeutics Corp

Watchlist Manager

Watchlist

Price: 466.1 EUR -4.33% Market Closed

Market Cap: €13.2B

U	United Therapeutics Corp SWB:UTH	US
	Fugro NV F:F3DC	NL
F	Finning International Inc SWB:CIH	CA
	Premia Finance SpA Societa di Mediazione Creditizia F:81U	IT
	Applovin Corp NASDAQ:APP	US

Profitability Summary

United Therapeutics Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

87%

Strong 3Y Average Gross Margin

89%

Declining Gross Margin

91% > 87%

Exceptional Operating Margin

45%

Strong 3Y Average Operating Margin

49%

Declining Operating Margin

50% > 45%

Exceptional Net Margin

41%

Strong 3Y Average Net Margin

41%

Net Margin is Increasing

37% > 41%

Exceptional Free Cash Flow Margin

32%

Strong 3Y Average Free Cash Flow Margin

34%

Declining Free Cash Flow Margin

36% > 32%

Positive ROE

20%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

28%

ROIC is Increasing

25% > 28%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.